North America Cell Therapy Market Size and Trends for 2026

The North America cell therapy market size was estimated at USD 4.12 billion in 2025 and is projected to grow to USD 28.99 billion by 2035, rising at a compound annual growth rate (CAGR) of 21.54% from 2026 to 2035.

Quick Facts

• Global cell therapy market to cover USD 8.85 billion by 2026.
• North America dominated the market share by 59%.
• Asia Pacific is expected to grow at a significant rate during the forecast period.
• By therapy type, the autologous therapy segment dominated the cell therapy market share by 50% in 2025.
• By therapeutic area, the oncology segment held the largest share of the market in 2025.

Cell Therapy Market: Novel Therapies

The delivery of chosen, modified, or changed cells outside of the body for the purpose of treating or preventing illness is known as cell therapy. With intriguing and developing potential for therapeutic use, cell therapy is a field on the rise. The manufacturing and culturing procedures must develop before these medicines may be used commercially, which usually entails drastically scaling up and automating to match the clinical demand. Over the past twenty years, research at government and university institutions throughout the globe has substantially advanced our knowledge of cell treatments. Different cell types will be researched for possible uses and developed into treatments as innovative cell therapies while the study is still in its early stages.

Top Companies in the Cell Therapy Market

• Novartis AG
• 2seventy Bio Inc.
• Anterogen Co., Ltd.
• Johnson & Johnson Services, Inc
• Astellas Pharma Inc.
• M Aurion Biotech
• EDIPOST
• Atara Biotherapeutics
• JCR Pharmaceuticals Co., Ltd.
• S. BIOMEDICS
• Holostem Terapie Avanzate S.r.l
• Bristol-Myers Squibb Company
• JW Therapeutics
• Nkarta, Inc.
• Gilead Sciences, Inc.

Segments Covered in the Report

By Therapy Type

• Autologous Therapies
  • Stem Cell Therapies
    • BM, Blood, & Umbilical Cord-derived Stem Cells
    • Adipose-Derived Cells
    • Others
  • Non-Stem Cell Therapies
    • T-Cell Therapies
      • CAR T Cell Therapy
      • T Cell Receptor (TCR)-based
    • Others
• Allogeneic Therapies
  • Stem Cell Therapies
    • Hematopoietic Stem Cell Therapies
    • Mesenchymal Stem Cell Therapies
  • Non-Stem Cell Therapies
    • Keratinocytes & Fibroblast-based Therapies
    • Others

By Therapeutic Area

• Oncology
  • Hematological malignancies
    • Leukemia
    • Lymphoma
    • Multiple myeloma
  • Solid tumors
    • Lung cancer
    • Breast cancer
    • Prostate cancer
    • Ovarian cancer
    • Glioblastoma
  • Post-transplant relapse management
  • Cancer immunotherapy combinations
• Musculoskeletal Disorders
  • Osteoarthritis
  • Rheumatoid arthritis
  • Cartilage regeneration
  • Tendon & ligament injuries
  • Bone defects & non-union fractures
  • Degenerative disc disease
• Cardiovascular Diseases (CVD)
  • Ischemic heart disease
  • Myocardial infarction
  • Heart failure
  • Peripheral artery disease (PAD)
  • Stroke & ischemic injury repair
  • Vascular regeneration therapies
• Dermatology
  • Chronic wounds
  • Burns & trauma
  • Diabetic foot ulcers
  • Vitiligo
  • Psoriasis
  • Skin aging & regenerative aesthetics
• Others
  • Neurological disorders
    • Parkinson’s disease
    • Alzheimer’s disease
    • Spinal cord injury
  • Autoimmune diseases
  • Ophthalmic disorders
  • Gastrointestinal disorders
  • Rare genetic diseases